Navneet Upadhyay

Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial

Barry A. Borlaug, Michael R. Zile, Christopher M. Kramer et al. · Nature Medicine · 2024 · 118 citations · Full text

Medicine, Cardiology, Pharmacology +15

Cost-effectiveness of pembrolizumab compared with chemotherapy in the US for women with previously treated deficient mismatch repair or high microsatellite instability unresectable or metastatic endometrial cancer

Elizabeth Thurgar, Mark Gouldson, Suzette M. Matthijsse et al. · Journal of Medical Economics · 2021 · 36 citations · Full text

Medicine, Oncology, Pharmacoeconomics +16

The association between geographic access to providers and the treatment quality of pediatric depression

Navneet Upadhyay, Rajender R. Aparasu, Paul J. Rowan et al. · Journal of Affective Disorders · 2019 · 20 citations

Medicine, Child Health, Pediatrics +14

Tirzepatide compared with semaglutide and 10-year cardiovascular disease risk reduction in obesity: <i>post-hoc</i> analysis of the SURMOUNT-5 trial

Mamas Mamas, Harold Bays, Navneet Upadhyay et al. · European Heart Journal Open · 2025 · 15 citations · Full text

Medicine, Pharmacotherapy, Preventive Medicine +17

The Impact of Pharmacotherapy on Substance Use in Adolescents With Attention-Deficit/Hyperactivity Disorder: Variations Across Subtypes

Navneet Upadhyay, Hua Chen, Osaro Mgbere et al. · Substance Use & Misuse · 2017 · 12 citations

Medicine, Pharmacotherapy, Psychiatry +16